Journal
BIOCHIMIE
Volume 156, Issue -, Pages 148-157Publisher
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.biochi.2018.10.006
Keywords
microRNAs; Tumor resistance; Radiosenstivity; Radioresistance; Esophageal cancer
Categories
Funding
- Department of Science and Technology of India through the Ramanujan Fellowship [SR/S2/RJN-95/2011, SR/S2/RJN-03/2012]
- NIH/NCI [CA093729]
- Department of Biotechnology, India [6242-P30/RGCB/PMD/DBT/AKJN/2015]
- Indian Council of Medical Research [5/13/81/2013-NCD-III]
- Central University of Punjab
Ask authors/readers for more resources
The five-year survival rate of esophageal cancer patients is less than 20%. This may be due to increased resistance (acquired or intrinsic) of tumor cells to chemo/radiotherapies, often caused by aberrant cell cycle, deregulated apoptosis, increases in growth factor signaling pathways, and/or changes in the proteome network. In addition, deregulation in non-coding RNA-mediated signaling pathways may contribute to resistance to therapies. At the molecular level, these resistance factors have now been linked to various microRNA (miRNAs), which have recently been shown to control cell development, differentiation and neoplasia. The increased stability and dysregulated expression of miRNAs have been associated with increased resistance to various therapies in several cancers, including esophageal cancer. Therefore, miRNAs represent the next generation of molecules with tremendous potential as biomarkers and therapeutic targets. However, detailed studies on miRNA-based therapeutic interventions are still in their infancy. Hence, in this review, we have summarized the current status of microRNAs in dictating the resistance/sensitivity of tumor cells to chemotherapy and radiotherapy. In addition, we have discussed various strategies to increase radiosensitivity, including targeted therapy, and the use of miRNAs as radiosensitive/radioresistance biomarkers for esophageal cancer in the clinical setting. (c) 2018 Published by Elsevier B.V.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available